As of 2025-06-08, the Relative Valuation of Sunshine Biopharma Inc (SBFM) is 0.22 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.51 USD, the upside of Sunshine Biopharma Inc based on Relative Valuation is -85.4%.
The range of the Relative Valuation is (0.13) - 0.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.2x |
| Forward P/E multiples | -0.7x - -0.4x | -0.5x |
| Fair Price | (0.13) - 0.42 | 0.22 |
| Upside | -108.8% - -72.2% | -85.4% |
| Date | P/E |
| 2025-06-06 | -1.37 |
| 2025-06-05 | -1.34 |
| 2025-06-04 | -1.37 |
| 2025-06-03 | -1.41 |
| 2025-06-02 | -1.29 |
| 2025-05-30 | -1.30 |
| 2025-05-29 | -1.31 |
| 2025-05-28 | -1.31 |
| 2025-05-27 | -1.30 |
| 2025-05-23 | -1.31 |
| 2025-05-22 | -1.27 |
| 2025-05-21 | -1.29 |
| 2025-05-20 | -1.36 |
| 2025-05-19 | -1.35 |
| 2025-05-16 | -1.36 |
| 2025-05-15 | -1.20 |
| 2025-05-14 | -1.26 |
| 2025-05-13 | -1.23 |
| 2025-05-12 | -1.22 |
| 2025-05-09 | -1.13 |
| 2025-05-08 | -1.12 |
| 2025-05-07 | -1.15 |
| 2025-05-06 | -1.19 |
| 2025-05-05 | -1.15 |
| 2025-05-02 | -1.24 |
| 2025-05-01 | -1.28 |
| 2025-04-30 | -1.22 |
| 2025-04-29 | -1.26 |
| 2025-04-28 | -1.31 |
| 2025-04-25 | -1.37 |
| 2025-04-24 | -1.41 |
| 2025-04-23 | -1.33 |
| 2025-04-22 | -1.22 |
| 2025-04-21 | -1.17 |
| 2025-04-17 | -1.13 |
| 2025-04-16 | -1.11 |
| 2025-04-15 | -1.16 |
| 2025-04-14 | -1.19 |
| 2025-04-11 | -1.23 |
| 2025-04-10 | -1.25 |
| 2025-04-09 | -1.34 |
| 2025-04-08 | -1.30 |
| 2025-04-07 | -1.35 |
| 2025-04-04 | -1.42 |
| 2025-04-03 | -1.67 |
| 2025-04-02 | -2.04 |
| 2025-04-01 | -1.89 |
| 2025-03-31 | -1.73 |
| 2025-03-28 | -1.81 |
| 2025-03-27 | -1.90 |